Serum protein profiling of systemic lupus erythematosus and systemic sclerosis using recombinant antibody microarrays

Molecular and Cellular Proteomics

Volumn 10, Issue 5, 2011, Pages

  Carlsson, Anders ^a   Wuttge, Dirk M ^b   Ingvarsson, Johan ^a   Bengtsson, Anders A ^b   Sturfelt, Gunnar ^b   Borrebaeck, Carl A K ^a   Wingren, Christer ^a  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; RECOMBINANT ANTIBODY; PEPTIDE LIBRARY; PLASMA PROTEIN; PROTEOME; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; FEMALE; HUMAN; MALE; MICROARRAY ANALYSIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; VALIDATION PROCESS; AREA UNDER THE CURVE; BLOOD; CASE CONTROL STUDY; CHEMISTRY; GENE EXPRESSION PROFILING; MIDDLE AGED; PROGNOSIS; PROTEIN MICROARRAY; RECEIVER OPERATING CHARACTERISTIC;

ADULT; AGED; AREA UNDER CURVE; BIOLOGICAL MARKERS; BLOOD PROTEINS; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION PROFILING; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PEPTIDE LIBRARY; PHENOTYPE; PROGNOSIS; PROTEIN ARRAY ANALYSIS; PROTEOME; ROC CURVE; SCLERODERMA, SYSTEMIC; SINGLE-CHAIN ANTIBODIES; YOUNG ADULT;

EID: 79955747971     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M110.005033     Document Type: Article

References (67)

1. D'Cruz, D. P., Khamashta, M. A., and Hughes, G. R. (2007) Systemic lupus erythematosus. Lancet 369, 587-596
2. Rahman, A., and Isenberg, D. A. (2008) Systemic lupus erythematosus. New Engl. J. Med. 358, 929-939
3. Varga, J. (2008) Systemic sclerosis: an update. Bull. NYU Hosp. Joint Diseases 66, 198-202
4. Varga, J., and Abraham, D. (2007) Systemic sclerosis: a prototypic multisystem fibrotic disorder. J. Clin. Invest. 117, 557-567
5. Eisenberg, R. (2009) Why can't we find a new treatment for SLE?. J. Autoimmun. 32, 223-230
6. Liu, C. C., and Ahearn, J. M. (2009) The search for lupus biomarkers. Best Practice Res. 23, 507-523
7. Abraham, D. J., Krieg, T., Distler, J., and Distler, O. (2009) Overview of pathogenesis of systemic sclerosis. Rheumatology 48 Suppl 3, iii3-7
8. Matucci-Cerinic, M., Steen, V., Nash, P., and Hachulla, E. (2009) The complexity of managing systemic sclerosis: screening and diagnosis. Rheumatology 48 Suppl 3, iii8-13
9. Liu, C. C., Manzi, S., and Ahearn, J. M. (2005) Biomarkers for systemic lupus erythematosus: a review and perspective. Curr. Opin. Rheumatol. 17, 543-549
10. Rovin, B. H., Birmingham, D. J., Nagaraja, H. N., Yu, C. Y., and Hebert, L. A. (2007) Biomarker discovery in human SLE nephritis. Bull. NYU Hosp. Joint Diseases 65, 187-193
11. Rovin, B. H., and Zhang, X. (2009) Biomarkers for lupus nephritis: the quest continues. Clin. J. Am. Soc. Nephrol. 4, 1858-1865
12. Suh, C. H., and Kim, H. A. (2008) Cytokines and their receptors as biomarkers of systemic lupus erythematosus. Expert Rev. Mol. Diagnostics 8, 189-198
13. Hochberg, M. C. (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheumatism 40, 1725
14. Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., McShane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., and Winchester, R. J. (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheumatism 25, 1271-1277 (Pubitemid 13221242)
15. Sturfelt, G., and Sjöholm, A. G. (1984) Complement components, complement activation, and acute phase response in systemic lupus erythematosus. Int. Arch. Allergy Appl. Immunol. 75, 75-83
16. Eisen, M. B., Spellman, P. T., Brown, P. O., and Botstein, D. (1998) Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. U.S.A. 95, 14863-14868
17. Yamamoto, T. (2009) Scleroderma - pathophysiology. Eur. J. Dermatol. 19, 14-24
18. Mayes, M. D., Lacey, J. V., Jr., Beebe-Dimmer, J., Gillespie, B. W., Cooper, B., Laing, T. J., and Schottenfeld, D. (2003) Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheumatism 48, 2246-2255 (Pubitemid 36959206)
19. LeRoy, E. C., Black, C., Fleischmajer, R., Jablonska, S., Krieg, T., Medsger, T. A., Jr., Rowell, N., and Wollheim, F. (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J. Rheumatol. 15, 202-205 (Pubitemid 18073738)
20. Doran, J. P., and Veale, D. J. (2008) Biomarkers in systemic sclerosis. Rheumatology 47 Suppl 5, 36-38
21. Chen, C. H. (2008) Review of a current role of mass spectrometry for proteome research. Analyt. Chim. Acta 624, 16-36
22. Cravatt, B. F., Simon, G. M., and Yates, J. R., 3rd (2007) The biological impact of mass-spectrometry-based proteomics. Nature 450, 991-1000 (Pubitemid 350273629)
23. Hanash, S. M., Pitteri, S. J., and Faca, V. M. (2008) Mining the plasma proteome for cancer biomarkers. Nature 452, 571-579
24. Borrebaeck, C. A., and Wingren, C. (2009) Design of high-density antibody microarrays for disease proteomics: Key technological issues. J. Proteomics 72, 928-935
25. Haab, B. B. (2006) Applications of antibody array platforms. Curr Opin Biotechnol 17, 415-421
26. Kingsmore, S. F. (2006) Multiplexed protein measurement: technologies and applications of protein and antibody arrays. Nat. Rev. Drug Discov. 5, 310-320
27. Ingvarsson, J., Larsson, A., Sjöholm, A. G., Truedsson, L., Jansson, B., Borrebaeck, C. A., and Wingren, C. (2007) Design of recombinant antibody microarrays for serum protein profiling: targeting of complement proteins. J. Proteome Res. 6, 3527-3536 (Pubitemid 47522744)
28. Wingren, C., Ingvarsson, J., Dexlin, L., Szul, D., and Borrebaeck, C. A. (2007) Design of recombinant antibody microarrays for complex proteome analysis: choice of sample labeling-tag and solid support. Proteomics 7, 3055-3065
29. Borrebaeck, C. A., and Wingren, C. (2009) Transferring proteomic discoveries into clinical practice. Expert Rev. Proteomics 6, 11-13
30. Carlsson, A., Wingren, C., Ingvarsson, J., Ellmark, P., Baldertorp, B., Fernö, M., Olsson, H., and Borrebaeck, C. A. (2008) Serum proteome profiling of metastatic breast cancer using recombinant antibody microarrays. Eur. J. Cancer 44, 472-480
31. Ellmark, P., Ingvarsson, J., Carlsson, A., Lundin, B. S., Wingren, C., and Borrebaeck, C. A. (2006) Identification of protein expression signatures associated with Helicobacter pylori infection and gastric adenocarcinoma using recombinant antibody microarrays. Mol. Cell Proteomics 5, 1638-1646
32. Ingvarsson, J., Wingren, C., Carlsson, A., Ellmark, P., Wahren, B., Engström, G., Harmenberg, U., Krogh, M., Peterson, C., and Borrebaeck, C. A. (2008) Detection of pancreatic cancer using antibody microarraybased serum protein profiling. Proteomics 8, 2211-2219
33. Carlsson, A., Persson, O., Ingvarsson, J., Widegren, B., Salford, L., Borrebaeck, C. A., and Wingren, C. (2010) Plasma protein profiling reveals biomarker patterns associated with prognosis and therapy selection in glioblastoma multiforme patients. Proteomics - Clin. Appl. In press
34. Hesselstrand, R., Scheja, A., and Akesson, A. (1998) Mortality and causes of death in a Swedish series of systemic sclerosis patients. Ann. Rheumatic Dis. 57, 682-686
35. Ståhl-Hallengren, C., Jönsen, A., Nived, O., and Sturfelt, G. (2000) Incidence studies of systemic lupus erythematosus in Southern Sweden: increasing age, decreasing frequency of renal manifestations and good prognosis. J. Rheumatol. 27, 685-691 (Pubitemid 30151347)
36. Masi, A. T. (1988) Classification of systemic sclerosis (scleroderma): relationship of cutaneous subgroups in early disease to outcome and serologic reactivity. J. Rheumatol. 15, 894-898
37. Wuttge, D. M., Wildt, M., Geborek, P., Wollheim, F. A., Scheja, A., and Akesson, A. (2007) Serum IL-15 in patients with early systemic sclerosis: a potential novel marker of lung disease. Arthritis Res. Ther. 9, R85
38. Gladman, D. D., Ibañez, D., and Urowitz, M. B. (2002) Systemic lupus erythematosus disease activity index 2000. J. Rheumatol. 29, 288-291
39. Wingren, C., and Borrebaeck, C. A. (2008) Antibody microarray analysis of directly labelled complex proteomes. Curr. Opin. Biotechnol. 19, 55-61
40. Söderlind, E., Strandberg, L., Jirholt, P., Kobayashi, N., Alexeiva, V., Aberg, A. M., Nilsson, A., Jansson, B., Ohlin, M., Wingren, C., Danielsson, L., Carlsson, R., and Borrebaeck, C. A. (2000) Recombining germline-derived CDR sequences for creating diverse single-framework antibody libraries. Nat. Biotechnol. 18, 852-856
41. Borrebaeck, C. A., and Wingren, C. (2007) High-throughput proteomics using antibody microarrays: an update. Expert Rev. Mol. Diagn. 7, 673-686
42. Wingren, C., and Borrebaeck, C. A. (2006) Antibody microarrays: current status and key technological advances. Omics 10, 411-427
43. Wingren, C., and Borrebaeck, C. A. (2007) Progress in miniaturization of protein arrays - a step closer to high-density nanoarrays. Drug Discov. Today 12, 813-819
44. Wingren, C., Ingvarsson, J., Lindstedt, M., and Borrebaeck, C. A. (2003) Recombinant antibody microarrays-a viable option?. Nat. Biotechnol. 21, 223
45. Chih-chung, C., and Chih-Jen, L. (2007) LIBSVM: a library for support vector machines., http/::www.csie.ntu.edu.tw/cjlin/libsvm
46. Cristianini, N., and Shawe-Taylor, J. (2000) An Introduction to Support Vector Machines and Other Kernel-based Learning Methods. Cambridge Univeristy Press
47. Ihaka, R., and Gentleman, R. (1996) A language for data analysis and graphics. J. Comp. Graph Stat. 5, 299-314
48. Atamas, S. P., and White, B. (2003) Cytokine regulation of pulmonary fibrosis in scleroderma. Cytokine Growth Factor Rev. 14, 537-550 (Pubitemid 37296026)
49. Beirne, P., Pantelidis, P., Charles, P., Wells, A. U., Abraham, D. J., Denton, C. P., Welsh, K. I., Shah, P. L., du Bois, R. M., and Kelleher, P. (2009) Multiplex immune serum biomarker profiling in sarcoidosis and systemic sclerosis. Eur. Respir. J. 34, 1376-1382
50. Duan, H., Fleming, J., Pritchard, D. K., Amon, L. M., Xue, J., Arnett, H. A., Chen, G., Breen, P., Buckner, J. H., Molitor, J. A., Elkon, K. B., and Schwartz, S. M. (2008) Combined analysis of monocyte and lymphocyte messenger RNA expression with serum protein profiles in patients with scleroderma. Arthritis Rheumatism 58, 1465-1474
51. Radstake, T. R., van Bon, L., Broen, J., Hussiani, A., Hesselstrand, R., Wuttge, D. M., Deng, Y., Simms, R., Lubberts, E., and Lafyatis, R. (2009) The pronounced Th17 profile in systemic sclerosis (SSc) together with intracellular expression of TGFbeta and IFNgamma distinguishes SSc phenotypes. PloS one 4, e5903
52. Gerszten, R. E., Accurso, F., Bernard, G. R., Caprioli, R. M., Klee, E. W., Klee, G. G., Kullo, I., Laguna, T. A., Roth, F. P., Sabatine, M., Srinivas, P., Wang, T. J., and Ware, L. B. (2008) Challenges in translating plasma proteomics from bench to bedside: update from the NHLBI Clinical Proteomics Programs. Am. J. Physiol. 295, L16-22
53. Hanash, S. (2003) Disease proteomics. Nature 422, 226-232
54. Omenn, G. S., States, D. J., Adamski, M., Blackwell, T. W., Menon, R., Hermjakob, H., Apweiler, R., Haab, B. B., Simpson, R. J., Eddes, J. S., Kapp, E. A., Moritz, R. L., Chan, D. W., Rai, A. J., Admon, A., Aebersold, R., Eng, J., Hancock, W. S., Hefta, S. A., Meyer, H., Paik, Y. K., Yoo, J. S., Ping, P., Pounds, J., Adkins, J., Qian, X., Wang, R., Wasinger, V., Wu, C. Y., Zhao, X., Zeng, R., Archakov, A., Tsugita, A., Beer, I., Pandey, A., Pisano, M., Andrews, P., Tammen, H., Speicher, D. W., and Hanash, S. M. (2005) Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database. Proteomics 5, 3226-3245
55. Lorber, M., Gershwin, M. E., and Shoenfeld, Y. (1994) The coexistence of systemic lupus erythematosus with other autoimmune diseases: the kaleidoscope of autoimmunity. Sem. Arthritis Rheumatism 24, 105-113 (Pubitemid 24326548)
56. Pope, J. E. (2002) Scleroderma overlap syndromes. Curr. Opin. Rheumatol. 14, 704-710
57. Bauer, J. W., Baechler, E. C., Petri, M., Batliwalla, F. M., Crawford, D., Ortmann, W. A., Espe, K. J., Li, W., Patel, D. D., Gregersen, P. K., and Behrens, T. W. (2006) Elevated serum levels of interferon-regulated chemokines are biomarkers for active human systemic lupus erythematosus. PLoS Med. 3, e491
58. Bauer, J. W., Petri, M., Batliwalla, F. M., Koeuth, T., Wilson, J., Slattery, C., Panoskaltsis-Mortari, A., Gregersen, P. K., Behrens, T. W., and Baechler, E. C. (2009) Interferon-regulated chemokines as biomarkers of systemic lupus erythematosus disease activity: a validation study. Arthritis Rheumatism 60, 3098-3107
59. Suzuki, M., Ross, G. F., Wiers, K., Nelson, S., Bennett, M., Passo, M. H., Devarajan, P., and Brunner, H. I. (2007) Identification of a urinary proteomic signature for lupus nephritis in children. Ped. Nephrol. 22, 2047-2057
60. Villegas-Zambrano, N., Martínez-Taboada, V. M., Bolívar, A., San Martín, M., Alvarez, L., Marín, M. J., and López-Hoyos, M. (2009) Correlation between clinical activity and serological markers in a wide cohort of patients with systemic lupus erythematosus: an eight-year prospective study. Ann. N.Y. Acad. Sci. 1173, 60-66
61. Sjoholm, A. G., Martensson, U., and Sturfelt, G. (1997) Serial analysis of autoantibody responses to the collagen-like region of Clq, collagen type II, and double stranded DNA in patients with systemic lupus erythematosus. J. Rheumatol. 24, 871-878 (Pubitemid 27223621)
62. Sturfelt, G., Sjöholm, A. G., and Svensson, B. (1983) Complement components, C1 activation and disease activity in SLE. Int. Arch. Allergy Appl. Immunol. 70, 12-18
63. Mosley, K., Tam, F. W., Edwards, R. J., Crozier, J., Pusey, C. D., and Lightstone, L. (2006) Urinary proteomic profiles distinguish between active and inactive lupus nephritis. Rheumatology 45, 1497-1504 (Pubitemid 44817055)
64. Pitashny, M., Schwartz, N., Qing, X., Hojaili, B., Aranow, C., Mackay, M., and Putterman, C. (2007) Urinary lipocalin-2 is associated with renal disease activity in human lupus nephritis. Arthritis Rheumatism 56, 1894-1903 (Pubitemid 47110388)
65. Urquizu-Padilla, M., Balada, E., Cortés, F., Pérez, E. H., Vilardell-Tarrés, M., and Ordi-Ros, J. (2009) Serum levels of soluble CD40 ligand at flare and at remission in patients with systemic lupus erythematosus. J. Rheumatol. 36, 953-960
66. Fu, Q., Chen, X., Cui, H., Guo, Y., Chen, J., Shen, N., and Bao, C. (2008) Association of elevated transcript levels of interferon-inducible chemokines with disease activity and organ damage in systemic lupus erythematosus patients. Arthritis Res. Ther. 10, R112
67. Pascual, V., Farkas, L., and Banchereau, J. (2006) Systemic lupus erythematosus: all roads lead to type I interferons. Curr. Opin. Immunol. 18, 676-682